143 related articles for article (PubMed ID: 22581592)
21. Validation of sensitivity and specificity of tetraplet-primed PCR (TP-PCR) in the molecular diagnosis of myotonic dystrophy type 2 (DM2).
Catalli C; Morgante A; Iraci R; Rinaldi F; Botta A; Novelli G
J Mol Diagn; 2010 Sep; 12(5):601-6. PubMed ID: 20616365
[TBL] [Abstract][Full Text] [Related]
22. A PCR amplification method reveals instability of the dodecamer repeat in progressive myoclonus epilepsy (EPM1) and no correlation between the size of the repeat and age at onset.
Lalioti MD; Scott HS; Genton P; Grid D; Ouazzani R; M'Rabet A; Ibrahim S; Gouider R; Dravet C; Chkili T; Bottani A; Buresi C; Malafosse A; Antonarakis SE
Am J Hum Genet; 1998 Apr; 62(4):842-7. PubMed ID: 9529356
[TBL] [Abstract][Full Text] [Related]
23. Molecular genetic and clinical characterization of myotonic dystrophy type 1 patients carrying variant repeats within DMPK expansions.
Pešović J; Perić S; Brkušanin M; Brajušković G; Rakočević-Stojanović V; Savić-Pavićević D
Neurogenetics; 2017 Dec; 18(4):207-218. PubMed ID: 28942489
[TBL] [Abstract][Full Text] [Related]
24. PSP-Phenotype in SCA8: Case Report and Systemic Review.
Samukawa M; Hirano M; Saigoh K; Kawai S; Hamada Y; Takahashi D; Nakamura Y; Kusunoki S
Cerebellum; 2019 Feb; 18(1):76-84. PubMed ID: 29916049
[TBL] [Abstract][Full Text] [Related]
25. A molecular protocol for diagnosing myotonic dystrophy.
Guida M; Marger RS; Papp AC; Snyder PJ; Sedra MS; Kissel JT; Mendell JR; Prior TW
Clin Chem; 1995 Jan; 41(1):69-72. PubMed ID: 7813083
[TBL] [Abstract][Full Text] [Related]
26. Evidence for a relatively high proportion of DM2 mutations in a large group of Polish patients.
Sulek A; Lusakowska A; Krysa W; Rajkiewicz M; Kaminska A; Nojszewska M; Kostera-Pruszczyk A; Zdzienicka E; Kubalska J; Rakowicz M; Szirkowiec W; Kwiecinski H; Zaremba J
Neurol Neurochir Pol; 2018; 52(6):736-742. PubMed ID: 29588063
[TBL] [Abstract][Full Text] [Related]
27. A long PCR-based molecular protocol for detecting normal and expanded ZNF9 alleles in myotonic dystrophy type 2.
Bonifazi E; Vallo L; Giardina E; Botta A; Novelli G
Diagn Mol Pathol; 2004 Sep; 13(3):164-6. PubMed ID: 15322428
[TBL] [Abstract][Full Text] [Related]
28. Sequence configuration of spinocerebellar ataxia type 8 repeat expansions in a Japanese cohort of 797 ataxia subjects.
Hu Y; Hashimoto Y; Ishii T; Rayle M; Soga K; Sato N; Okita M; Higashi M; Ozaki K; Mizusawa H; Ishikawa K; Yokota T
J Neurol Sci; 2017 Nov; 382():87-90. PubMed ID: 29111027
[TBL] [Abstract][Full Text] [Related]
29. New analysis method of myotonic dystrophy 1 based on quantitative fluorescent polymerase chain reaction.
Skrzypczak-Zielinska M; Sulek-Piatkowska A; Mierzejewski M; Froster UG
Genet Test Mol Biomarkers; 2009 Oct; 13(5):651-5. PubMed ID: 19715468
[TBL] [Abstract][Full Text] [Related]
30. High throughput screening for expanded CTG repeats in myotonic dystrophy type 1 using melt curve analysis.
Butterfield RJ; Imburgia C; Mayne K; Newcomb T; Dunn DM; Duval B; Feldkamp ML; Johnson NE; Weiss RB
Mol Genet Genomic Med; 2021 Apr; 9(4):e1619. PubMed ID: 33624941
[TBL] [Abstract][Full Text] [Related]
31. Detection of large expansions in myotonic dystrophy type 1 using triplet primed PCR.
Singh S; Zhang A; Dlouhy S; Bai S
Front Genet; 2014; 5():94. PubMed ID: 24795756
[TBL] [Abstract][Full Text] [Related]
32. Presymptomatic diagnosis of myotonic dystrophy.
Brunner HG; Nillesen W; van Oost BA; Jansen G; Wieringa B; Ropers HH; Smeets HJ
J Med Genet; 1992 Nov; 29(11):780-4. PubMed ID: 1453426
[TBL] [Abstract][Full Text] [Related]
33. Effect of unexpected sequence interruptions to conventional PCR and repeat primed PCR in myotonic dystrophy type 1 testing.
Radvansky J; Ficek A; Minarik G; Palffy R; Kadasi L
Diagn Mol Pathol; 2011 Mar; 20(1):48-51. PubMed ID: 21326039
[TBL] [Abstract][Full Text] [Related]
34. Defining the performance parameters of a rapid screening tool for myotonic dystrophy type 1 based on triplet-primed PCR and melt curve analysis.
Lian M; Law HY; Lee CG; Chong SS
Expert Rev Mol Diagn; 2016 Nov; 16(11):1221-1232. PubMed ID: 27665623
[TBL] [Abstract][Full Text] [Related]
35. The First Case of Spinocerebellar Ataxia Type 8 in Monozygotic Twins.
Sawada J; Katayama T; Tokashiki T; Kikuchi S; Kano K; Takahashi K; Saito T; Adachi Y; Okamoto Y; Yoshimura A; Takashima H; Hasebe N
Intern Med; 2020 Jan; 59(2):277-283. PubMed ID: 31554751
[TBL] [Abstract][Full Text] [Related]
36. The expanding world of myotonic dystrophies: how can they be detected?
Radvansky J; Kadasi L
Genet Test Mol Biomarkers; 2010 Dec; 14(6):733-41. PubMed ID: 20939737
[TBL] [Abstract][Full Text] [Related]
37. SCA8 in the Spanish population including one homozygous patient.
Tazón B; Badenas C; Jiménez L; Muñoz E; Milà M
Clin Genet; 2002 Nov; 62(5):404-9. PubMed ID: 12431257
[TBL] [Abstract][Full Text] [Related]
38. Genetic and clinical analysis of spinocerebellar ataxia type 8 repeat expansion in Yugoslavia.
Topisirovic I; Dragasevic N; Savic D; Ristic A; Keckarevic M; Keckarevic D; Culjkovic B; Petrovic I; Romac S; Kostic VS
Clin Genet; 2002 Oct; 62(4):321-4. PubMed ID: 12372061
[TBL] [Abstract][Full Text] [Related]
39. New methods for molecular diagnosis and demonstration of the (CCTG)n mutation in myotonic dystrophy type 2 (DM2).
Sallinen R; Vihola A; Bachinski LL; Huoponen K; Haapasalo H; Hackman P; Zhang S; Sirito M; Kalimo H; Meola G; Horelli-Kuitunen N; Wessman M; Krahe R; Udd B
Neuromuscul Disord; 2004 Apr; 14(4):274-83. PubMed ID: 15019706
[TBL] [Abstract][Full Text] [Related]
40. Rapid touchdown PCR assay for the molecular diagnosis of spinocerebellar ataxia type 2.
Condorelli DF; Trovato-Salinaro A; Spinella F; Valvo S; Saponara R; Giuffrida S
Int J Clin Lab Res; 1998; 28(3):174-8. PubMed ID: 9801928
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
